We are live on
!
Find out more
AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+12.13%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$64.6M
AUM Growth
-$3.91M
(-5.7%)
Cap. Flow
-$8.9M
Cap. Flow
% of AUM
-13.78%
Top 10 Holdings %
Top 10 Hldgs %
18.76%
Holding
126
New
4
Increased
10
Reduced
102
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$554K |
| 2 |
Pegasystems
PEGA
|
+$496K |
| 3 |
Flywire
FLYW
|
+$455K |
| 4 |
Mercado Libre
MELI
|
+$366K |
| 5 |
First Solar
FSLR
|
+$66K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$584K |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$529K |
| 3 |
DexCom
DXCM
|
+$410K |
| 4 |
Shift4
FOUR
|
+$400K |
| 5 |
XYZ
Block Inc
XYZ
|
+$379K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.21% |
| 2 | Healthcare | 37.8% |
| 3 | Industrials | 6.21% |
| 4 | Financials | 5.54% |
| 5 | Communication Services | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLK
101
DELISTED
Splunk Inc
SPLK
| $288K | 0.45% |
2,715
-247
| -8% | -$23.5K |
|
102
Abbott
ABT
$180B
| $287K | 0.44% |
2,634
-556
| -17% | -$59.3K |
|
103
Agilent Technologies
A
$39.1B
| $286K | 0.44% |
2,379
-510
| -18% | -$65K |
|
104
Thermo Fisher Scientific
TMO
$211B
| $278K | 0.43% |
532
-106
| -17% | -$57.2K |
|
|
NARI
105
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $273K | 0.42% |
4,687
-1,070
| -19% | -$67.5K |
|
106
SentinelOne
S
$6.22B
| $267K | 0.41% |
17,709
-1,627
| -8% | -$27.5K |
|
107
Coherent
COHR
$55.2B
| $267K | 0.41% |
5,241
-1,381
| -21% | -$51.3K |
|
108
Okta
OKTA
$24.1B
| $266K | 0.41% |
3,832
-349
| -8% | -$26.5K |
|
|
RNAM
109
DELISTED
Avidity Biosciences
RNAM
| $249K | 0.39% |
22,438
-2,077
| -8% | -$26.1K |
|
110
Akamai
AKAM
$16.8B
| $247K | 0.38% |
2,747
-251
| -8% | -$21.5K |
|
|
NVEI
111
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $244K | 0.38% |
8,267
+1,222
| +17% | +$43.1K |
|
112
F5
FFIV
$22.1B
| $244K | 0.38% |
1,667
-151
| -8% | -$21.5K |
|
|
SPWR
113
DELISTED
SunPower Corporation Common Stock
SPWR
| $237K | 0.37% |
24,143
+2,035
| +9% | +$23.8K |
|
114
A10 Networks
ATEN
$2.47B
| $220K | 0.34% |
15,059
-1,382
| -8% | -$20K |
|
115
Virgin Galactic
SPCE
$320M
| $210K | 0.32% |
2,702
-146
| -5% | -$11.6K |
|
|
ICPT
116
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $206K | 0.32% |
18,581
-1,251
| -6% | -$17.4K |
|
117
Arvinas
ARVN
$518M
| – | – |
-7,080
| Closed | -$193K |
|
118
Fate Therapeutics
FATE
$281M
| – | – |
-13,035
| Closed | -$74.3K |
|
119
Fidelity National Information Services
FIS
$21.5B
| – | – |
-4,201
| Closed | -$228K |
|
120
Global Payments
GPN
$22.1B
| – | – |
-3,416
| Closed | -$360K |
|
121
Nkarta
NKTX
$162M
| – | – |
-20,111
| Closed | -$71.4K |
|
122
Omnicell
OMCL
$1.86B
| – | – |
-2,851
| Closed | -$167K |
|
123
Teladoc Health
TDOC
$1.58B
| – | – |
-8,565
| Closed | -$222K |
|
124
Tandem Diabetes Care
TNDM
$1.17B
| – | – |
-7,378
| Closed | -$300K |
|
|
CTLT
125
DELISTED
CATALENT, INC.
CTLT
| – | – |
-8,049
| Closed | -$529K |
|
Similar funds
JCI
SC
AOGP
ACJ
UFG
KC
P
AMC
AtonRa Partners's Q2 2023 Portfolio in Review
As of Q2 2023, AtonRa Partners held 126 positions worth $64.6M, down 5.7% from $68.5M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
AtonRa Partners withdrew a net $8.9M in Q2 2023, closing 10 positions and reducing 102 holdings. Its most notable exit was CATALENT, INC., an estimated $529K position sold in full.
By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 48% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, AtonRa Partners opened a new position in Evolent Health worth $519K.
- AtonRa Partners's largest Q2 2023 buy was Evolent Health: 17,124 shares worth $519K.
- AtonRa Partners added most to First Solar in Q2 2023, an estimated $66K increase.
- AtonRa Partners's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $584K.
- AtonRa Partners fully exited CATALENT, INC. in Q2 2023, selling an estimated $529K.
- AtonRa Partners's ten largest holdings make up 19% of its $64.6M portfolio in Q2 2023.
- AtonRa Partners opened 4 new positions and closed 10 in Q2 2023.
- AtonRa Partners's portfolio value fell 5.7% quarter-over-quarter to $64.6M.
Based on AtonRa Partners's 13F filing for Q2 2023, filed 18 Jul 2023.